Search Results
Chapter
Dry powder vaccines for mucosal administration: Critical factors in manufacture and delivery
January 01, 2012
Article
Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1 (vol 28, pg 6901, 2010)
March 01, 2011
Article
Prospects in Nasal Vaccination Against Clinically Relevant Pathogens and Select Agents
August 01, 2011
Article
Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia
September 01, 2011
Article
Cellular response to the deposition of diesel exhaust particle aerosols onto human lung cells grown at the air–liquid interface by inertial impaction
December 01, 2011
Article
In vitro characterization of nebulizer delivery of liposomal amphotericin B aerosols
November 01, 2011
Chapter
Dry powder vaccines for mucosal administration: Critical factors in manufacture and delivery
January 01, 2012
Article
Stable dry powder formulation for nasal delivery of anthrax vaccine
January 01, 2012
Chapter
Swift, measurement of pharmaceutical and diagnostic inhalation aerosols
July 01, 2011
Article
The effect of liposome encapsulation on the pharmacokinetics of Recombinant Secretory Leukocyte Protease Inhibitor (rSLPI) therapy after local delivery to a guinea pig asthma model
September 01, 2011
Book
Controlled Pulmonary Drug Delivery
July 01, 2011
Article
Guinea pig model of infectious disease - Viral infections
June 01, 2011